Endogenous mast cell degranulation modulates cervical contractility in the guinea pig

Am J Obstet Gynecol. 2002 Mar;186(3):438-45. doi: 10.1067/mob.2002.120488.

Abstract

Objective: The purpose of this study was to investigate the effect of endogenous mast cell degranulation on the contractility of isolated cervical strips from nonpregnant and pregnant guinea pigs.

Study design: Longitudinal cervical strips from nonpregnant and pregnant (mid and term) guinea pigs were used for isometric tension recording. Responses to the mast cell degranulating agent, compound 48/80, were compared in the absence or presence of different inhibitors and receptor antagonists. Concentration-response curves were obtained to histamine and 5-hydroxytryptamine in strips that were incubated with antagonists or solvent.

Results: Compound 48/80 and histamine significantly increased contractility of cervical strips in all 3 groups of animals. The inhibitor of mast cell degranulation significantly reduced responses to compound 48/80 and histamine-1 receptor antagonist reduced responses to histamine in all 3 groups. Histamine-1 receptor antagonist significantly inhibited responses to compound 48/80 in nonpregnant and mid pregnant guinea pigs. Histamine-2 receptor antagonist did not alter responses to compound 48/80 nor to histamine. The receptor antagonist 5-hydroxytryptamine-2 significantly inhibited cervical contractility that was induced by compound 48/80 in tissues from mid pregnant and term pregnant guinea pigs. Lipoxygenase inhibitor was effective in mid pregnant guinea pigs. Cyclooxygenase inhibitor, 5-hydroxytryptamine, and a combination of lipoxygenase and cyclooxygenase inhibitors had no effect on cervical contractility.

Conclusion: The degranulation of mast cells releases histamine and other mediators that stimulate cervical contractility through histamine-1 receptors. Cervical infiltration and modulation of contractility by mast cells may play an important physiologic and/or pathologic role in the control of cervical function during pregnancy.

MeSH terms

  • Animals
  • Cell Degranulation / physiology*
  • Cervix Uteri / drug effects
  • Cervix Uteri / physiology*
  • Chlorpheniramine / pharmacology
  • Cimetidine / pharmacology
  • Dose-Response Relationship, Drug
  • Female
  • Guinea Pigs
  • Histamine / pharmacology
  • Histamine H1 Antagonists / pharmacology
  • Histamine H2 Antagonists / pharmacology
  • In Vitro Techniques
  • Mast Cells / physiology*
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology*
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / physiology*
  • Osmolar Concentration
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy Trimester, Third
  • Serotonin / pharmacology
  • p-Methoxy-N-methylphenethylamine / pharmacology

Substances

  • Histamine H1 Antagonists
  • Histamine H2 Antagonists
  • Serotonin
  • Chlorpheniramine
  • p-Methoxy-N-methylphenethylamine
  • Cimetidine
  • Histamine